This discovery is accompanied by an observed association with the absence of CD22, with the presence of HLA-DRB1*07:01:01 identified as having a protective role in patients with CLL, indicating a protective role of these two markers in these patients. The gene discussed is CD22; the disease is B-cell chronic lymphocytic leukemia.